Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects
Clinical trial NCT04514237 · COMPLETED
Trial details
- NCT number
- NCT04514237
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-12
- Primary completion
- 2020-01-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.